Expanded newborn screening identifies maternal primary carnitine deficiency.
Article Details
- CitationCopy to clipboard
Schimmenti LA, Crombez EA, Schwahn BC, Heese BA, Wood TC, Schroer RJ, Bentler K, Cederbaum S, Sarafoglou K, McCann M, Rinaldo P, Matern D, di San Filippo CA, Pasquali M, Berry SA, Longo N
Expanded newborn screening identifies maternal primary carnitine deficiency.
Mol Genet Metab. 2007 Apr;90(4):441-5. Epub 2006 Nov 28.
- PubMed ID
- 17126586 [ View in PubMed]
- Abstract
Primary carnitine deficiency impairs fatty acid oxidation and can result in hypoglycemia, hepatic encephalopathy, cardiomyopathy and sudden death. We diagnosed primary carnitine deficiency in six unrelated women whose unaffected infants were identified with low free carnitine levels (C0) by newborn screening using tandem mass spectrometry. Given the lifetime risk of morbidity or sudden death, identification of adult patients with primary carnitine deficiency is an added benefit of expanded newborn screening programs.